TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/17/21 08:52 | 9/15/21 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Jones Aranthan II | DC | O | Chief Co | S.d | -277 | 16.49 | 0 | -17 | -17 | 82 | D | ||||||||||||||
7/27/21 16:37 | 7/26/21 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Jones Aranthan II | DC | O | Chief Co | S | -143 | 19.69 | 0 | -7 | -8 | 87 | D | ||||||||||||||
3/16/21 16:20 | 3/15/21 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Jones Aranthan II | DC | O | Chief Co | S.d | -319 | 17.72 | 0 | -18 | -16 | 94 | D | ||||||||||||||
3/3/21 18:40 | 3/2/21 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Jones Aranthan II | DC | O | Chief Co | S | -70 | 18.04 | 0 | -4 | -4 | 97 | D | ||||||||||||||
8/14/20 16:39 | 8/12/20 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Jones Aranthan II | DC | O | Chief Co | S | -85 | 11.81 | 0 | -7 | -9 | 75 | D | ||||||||||||||
7/29/20 20:17 | 7/27/20 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Jones Aranthan II | DC | O | Chief Co | S | -78 | 10.62 | 0 | -7 | -8 | 83 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |